Skip to main content
. 2017 Mar 21;7:45117. doi: 10.1038/srep45117

Figure 6. The incidence of adverse reactions in the nicorandil group and the control group (RR = 0.54, 95% CI 0.35~0.83, P = 0.073).

Figure 6